|
|
|||||
|
|
|
||||
|
|
|||||
|
text
|
|
||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|
||||
|
|
|||||
|
|
|
||||
|
|
|
|
|
|
|
|
• Concerns about physical, emotional and psycho-social effects
of conventional stimulation
• Cost of conventional stimulation
• Lack of public funding
• Risks associated with multiple pregnancies and births
• Move towards Single Embryo Transfe
• Clinical availability of antagonists
• Advances in Endocrinology
• Latest Ultrasound Technology
• Improved Embryology
• Increased demand for ART
• Cancer survivors requiring ART
• “Cost” of conventional stimulation IVF
• Need to offer more treatments on public health service
|